Eli Lilly and Company vs AbbVie Inc.
Eli Lilly and Company is worth $1.061T, 2.3× the $464.575B market cap of AbbVie Inc.. Updated daily.
| Metric | AbbVie Inc.ABBV  | |
|---|---|---|
| Market cap | $1.061T | $464.575B |
| Global rank | #1 | #2 |
| Share price | $1,189.41 | $262.90 |
| Change | -2.11% | +5.12% |
| Revenue | $65.179B | $61.160B |
| Net income | $20.640B | $4.226B |
| Country | United States | United States |
| Sector | Healthcare | Healthcare |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is Eli Lilly and Company bigger than AbbVie Inc.?
- Eli Lilly and Company has a market cap of $1.061T against $464.575B for AbbVie Inc., making it 2.3 times as valuable.
- Which company earns more, LLY or ABBV?
- Eli Lilly and Company reported net income of $20.640B and AbbVie Inc. reported $4.226B in their most recent annual periods.